Raymond James Financial’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.6M Buy
491,685
+27,332
+6% +$1.36M 0.01% 1446
2026
Q2
$21.9M Sell
464,353
-92,107
-17% -$4.73M 0.01% 1492
2026
Q1
$32.7M Sell
556,460
-54,291
-9% -$3.52M 0.01% 1132
2025
Q4
$37.9M Sell
610,751
-27,181
-4% -$1.66M 0.01% 999
2025
Q3
$39.8M Buy
637,932
+86,373
+16% +$6.01M 0.01% 946
2025
Q2
$44M Sell
551,559
-16,619
-3% -$1.39M 0.02% 837
2025
Q1
$48.8M Buy
568,178
+22,738
+4% +$1.87M 0.02% 734
2024
Q4
$42.6M Buy
+545,440
New +$42.3M 0.02% 814

Other funds holding PBH

Raymond James Financial's PBH Position: Q3 2026 in Review

Raymond James Financial increased its Prestige Consumer Healthcare (PBH) stake by 5.9% in Q3 2026, buying an estimated $1.36M and bringing the position to 491,685 shares worth $22.6M. The position accounts for 0.01% of the portfolio, ranked #1446.

Raymond James Financial first reported a position in PBH in Q4 2024 and has held it in 8 quarters since. The position peaked at $48.8M in Q1 2025. 335 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

  • Raymond James Financial held 491,685 shares of Prestige Consumer Healthcare worth $22.6M as of Q3 2026.
  • Raymond James Financial bought 27,332 Prestige Consumer Healthcare shares in Q3 2026, an estimated $1.36M.
  • Prestige Consumer Healthcare made up 0.01% of Raymond James Financial's portfolio in Q3 2026, its #1446 holding.
  • Raymond James Financial first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Prestige Consumer Healthcare position peaked at $48.8M in Q1 2025.
  • 335 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.